Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
A Q&A With Paul Heidenreich, MD
A Q&A With Milton Packer, MD
A Q&A With Gary Besinque, PharmD
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds
3
Rheumatoid Arthritis Linked to Elevated Pneumonia Risk, Especially in Seropositive Disease
4
Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD
5
